In particular, plasma phosphorylated tau 217 (p-tau217) has excellent agreement with amyloid positron emission tomography (PET) and autopsy data6–8, and was recently recommended as a core AD biomarker9. The gene discussed is MAPT; the disease is Alzheimer disease.